In addition, the prognostic significance of CSNK2A1 in human cancer patients has been reported in various types of cancers, such as breast cancer [10], clear cell renal cell carcinoma [8,37], colon cancer [4,38], gastric cancer [5], and prostatic cancer [9]. This evidence concerns the gene CSNK2A1 and colonic neoplasm.